
    
      This will be an open label, prospective, interventional, proof of concept study to evaluate
      the feasibility and safety of kidney transplant from HCV positive donors into HCV negative
      recipients using Sofosbuvir/Velpatasvir as a treatment for post-transplant HCV transmission
    
  